Company Sangui Biotech International, Inc. Other OTC
Equities
SGBI
US80105B1017
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 05-02-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 05-02-06 |
Hubertus Schmelz
BRD | Director/Board Member | 68 | 08-12-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 209,955,598 | 182,538,524 ( 86.94 %) | 53,756 ( 0.0256 %) | 86.94 % |
Company contact information
Sangui BioTech International, Inc.
Bleichenbruecke 9
20354, Hamburg
+49 40 609 3120
http://www.sanguibiotech.comSector
1st Jan change | Capi. | |
---|---|---|
+1.45% | 42.86B | |
+11.65% | 42.74B | |
+45.04% | 41.36B | |
-8.83% | 27.68B | |
+7.70% | 25.15B | |
-23.10% | 18.63B | |
+30.43% | 12.37B | |
-2.19% | 11.92B | |
+7.38% | 11.21B |